9.6 PLN
52.45 M PLN
446.87 M PLN
4.14 M
About SYNEKTIK
Sector
Industry
CEO
Cezary Dariusz Kozanecki
Website
Headquarters
Warsaw
Founded
2001
ISIN
PLSNKTK00019
FIGI
BBG001Y31JK8
Synektik SA provides medical and information technology solutions. It provides robotic systems for surgical support called da Vinci. It also develops software for medical diagnostics and tests. The company operates through the following segments: Sale of Medical Equipment and IT Solutions, and Radiopharmaceutical Production and Sale. The Sale of Medical Equipment and IT Solutions segment sells devices and delivers pre-ordered turnkey diagnostic laboratories. It also offers IT applications for the archiving of medical data related to diagnostic examinations. The Radiopharmaceutical Production and Sale segment is a manufacturer of radiopharmaceuticals for oncological treatment. The company was founded by Cezary Dariusz Kozanecki, Dariusz Marcin Korecki and Tomasz Warmus on October 4, 2001 and is headquartered in Warsaw, Poland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SNT is 181.0 PLN — it has increased by 1.69% in the past 24 hours. Watch SYNEKTIK stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange SYNEKTIK stocks are traded under the ticker SNT.
SNT stock has risen by 0.56% compared to the previous week, the month change is a 1.57% rise, over the last year SYNEKTIK has showed a 166.96% increase.
We've gathered analysts' opinions on SYNEKTIK future price: according to them, SNT price has a max estimate of 214.00 PLN and a min estimate of 200.00 PLN. Watch SNT chart and read a more detailed SYNEKTIK stock forecast: see what analysts think of SYNEKTIK and suggest that you do with its stocks.
SNT stock is 1.69% volatile and has beta coefficient of 0.89. Track SYNEKTIK stock price on the chart and check out the list of the most volatile stocks — is SYNEKTIK there?
Today SYNEKTIK has the market capitalization of 1.54 B, it has decreased by −2.17% over the last week.
Yes, you can track SYNEKTIK financials in yearly and quarterly reports right on TradingView.
SNT net income for the last quarter is 16.74 M PLN, while the quarter before that showed 12.23 M PLN of net income which accounts for 36.87% change. Track more SYNEKTIK financial stats to get the full picture.
Yes, SNT dividends are paid annually. The last dividend per share was 3.03 PLN. As of today, Dividend Yield (TTM)% is 1.67%. Tracking SYNEKTIK dividends might help you take more informed decisions.
SYNEKTIK dividend yield was 5.00% in 2023, and payout ratio reached 49.27%. The year before the numbers were 2.15% and 49.68% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNEKTIK EBITDA is 122.94 M PLN, and current EBITDA margin is 18.81%. See more stats in SYNEKTIK financial statements.
Like other stocks, SNT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNEKTIK stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNEKTIK technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNEKTIK stock shows the buy signal. See more of SYNEKTIK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.